We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Medical Devices Could Be Powered by Body’s Natural Battery

By HospiMedica International staff writers
Posted on 29 Nov 2012
A new study demonstrates that endocochlear potential (EP), a battery-like electrochemical gradient found in and actively maintained by the inner ear, could power implantable electronic devices.

Researchers from the Massachusetts Institute of Technology (MIT; Cambridge, USA), the Massachusetts Eye and Ear Infirmary (MEEI; Boston, USA), and Harvard University (Boston, MA, USA) demonstrated for the first time that this EP could power implantable electronic devices, without impairing hearing. More...
The devices could monitor biological activity or responses to therapies in people with hearing or balance impairments, and might eventually even deliver therapies themselves.

The researchers designed an anatomically sized, ultra-low quiescent-power energy harvester chip that was integrated with a wireless sensor capable of monitoring the EP itself. The researchers succeeded in extracting a minimum of 1.12 nW from the EP of a guinea pig for up to 5 hours, enabling a 2.4 GHz radio to transmit measurement of the EP every 40-360 seconds. After the implantation, the guinea pigs responded normally to hearing tests, and the devices were able to wirelessly transmit data about the chemical conditions of the ear to an external receiver. The study was published on November 8, 2012, in Nature Biotechnology.

“We have known for 60 years that this battery exists and that it’s really important for normal hearing, but nobody has attempted to use this battery to power useful electronics,” said study coauthor Konstantina Stankovic, an otologic surgeon at MEEI. “With future optimization of electrode design, we envision using the biologic battery in the inner ear to power chemical and molecular sensors, or drug-delivery actuators for diagnosis and therapy of hearing loss and other disorders.”

The ear converts the vibrations of the eardrum into an electrochemical signal that can be processed by the brain; the biological battery is the source of that signal’s current. Located in the cochlea, the battery chamber is divided by a membrane, some of whose cells are specialized to pump ions. An imbalance of potassium and sodium ions on opposite sides of the membrane, together with the particular arrangement of the pumps, creates the electrical voltage.

Related Links:
Massachusetts Institute of Technology
Massachusetts Eye and Ear Infirmary
Harvard University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.